摘要
目的:观察有晶状体眼Verisyse前房虹膜夹型人工晶状体植入矫治高度近视术后的视力、屈光状态以及相关并发症,评价其临床应用价值。方法:自2006-07/2008-07接受Verisyse人工晶状体植入术的32例48眼,术前平均球镜当量-15.65±3.41D。统计术后6mo;1a裸眼视力,最佳矫正视力、屈光度、内皮细胞计数,分析并发症的发生情况。结果:术后裸眼视力:0.4～1.0,平均0.75±0.34。术前最佳矫正视力:0.3～1.0,平均0.58±0.27,术后最佳矫正视力0.64±0.30。达到术前矫正42眼(87.5%),超过术前最佳矫正视力14眼(29.2%),随访6mo;1a,无明显变化。术前屈光平均球镜当量-15.65±3.41D;术后屈光度数平均球镜当量-1.58±2.47D。角膜内皮细胞计数术前(3108±265)个/mm2,术后6mo为(3054±317)个/mm2,差异无统计学意义。未见威胁视力的并发症。结论:有晶状体眼前房虹膜夹型人工晶状体植入矫治超高度近视安全有效,术后屈光效果令人满意。对眼内的长期影响需要进一步观察。
AIM：To study the efficacy and safety of the intraocular lens（IOL） implantation in phakic eyes for high myopia.·METHODS：Forty-eight eyes in 32 patients with-15.65±3.41 diopters（D） of myopia,-2.42±1.27D of astigmatism were performed implantation of phakic IOL.Uncorrected visual acuity（UCVA）;Best corrected visual acuity（BCVA）,refration,endothelial cells were recorded and studied.·RESULTS：UCVA 0.75±0.34 were achieved after operation.87.5% of eyes achieved BCVA,29.2% vision were better than BCVA.The mean refractive diopters were-15.65±3.41D pre-operatively and-1.58±2.47D post-operatively.There were no significant differences between the preoperative,6 months and one year postoperatively in mean counts of endothelial cells.·CONCLUSION：The implantation of phakic IOL for high myopia seems to be safe and effective,but still need a long-term observation in clinic.
出处
《国际眼科杂志》
CAS
2009年第11期2222-2223,共2页
International Eye Science
